Peptides for T cell selection in the thymus.


Journal

Peptides
ISSN: 1873-5169
Titre abrégé: Peptides
Pays: United States
ID NLM: 8008690

Informations de publication

Date de publication:
12 2021
Historique:
received: 09 09 2021
revised: 29 09 2021
accepted: 30 09 2021
pubmed: 9 10 2021
medline: 24 3 2022
entrez: 8 10 2021
Statut: ppublish

Résumé

Major histocompatibility complex (MHC)-associated peptides generated and displayed by antigen-presenting cells in the thymus are essential for the generation of functional and self-tolerant T cells that protect our body from various pathogens. The peptides displayed by cortical thymic epithelial cells (cTECs) are generated by unique enzymatic machineries including the thymoproteasomes, and are involved in the positive selection of self-protective T cells. On the other hand, the peptides displayed by medullary thymic epithelial cells (mTECs) and thymic dendritic cells (DCs) are involved in further selection to establish self-tolerance in T cells. Although the biochemical nature of the peptide repertoire displayed in the thymus remains unclear, many studies have suggested a thymus-specific mechanism for the generation of MHC-associated peptides in the thymus. In this review, we summarize basic knowledge and recent advances in MHC-associated thymic peptides, focusing on the generation and function of thymoproteasome-dependent peptides specifically displayed by cTECs.

Identifiants

pubmed: 34624431
pii: S0196-9781(21)00179-0
doi: 10.1016/j.peptides.2021.170671
pmc: PMC9309017
mid: NIHMS1819985
pii:
doi:

Substances chimiques

Histocompatibility Antigens Class I 0
Peptides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

170671

Subventions

Organisme : Intramural NIH HHS
ID : ZIA BC011806
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Nat Immunol. 2018 Sep;19(9):923-931
pubmed: 30104634
Cell Rep. 2019 Jan 15;26(3):639-651.e2
pubmed: 30650357
Cell Rep. 2021 Sep 7;36(10):109546
pubmed: 34496243
Immunity. 1999 Jan;10(1):1-7
pubmed: 10023765
Nature. 2008 Sep 18;455(7211):396-400
pubmed: 18701890
Eur J Immunol. 2018 Mar;48(3):419-429
pubmed: 29067678
Nat Immunol. 2011 Dec 25;13(2):129-35
pubmed: 22197977
Eur J Immunol. 2001 Aug;31(8):2476-86
pubmed: 11500832
Cell Rep. 2021 Sep 7;36(10):109657
pubmed: 34496235
Nature. 1995 Jun 29;375(6534):795-8
pubmed: 7596413
J Immunol. 2017 Dec 1;199(11):3748-3756
pubmed: 29061767
J Exp Med. 2000 May 1;191(9):1513-24
pubmed: 10790426
J Exp Med. 2017 Jul 3;214(7):1925-1935
pubmed: 28611158
Immunity. 2010 Jan 29;32(1):29-40
pubmed: 20045355
Eur J Immunol. 2013 Sep;43(9):2273-82
pubmed: 23719902
J Exp Med. 2004 Oct 18;200(8):1039-49
pubmed: 15492126
Semin Immunopathol. 2021 Feb;43(1):5-14
pubmed: 33415360
Trends Cell Biol. 1992 Jul;2(7):202-7
pubmed: 14731501
J Immunol. 2015 Sep 1;195(5):1964-73
pubmed: 26209627
Science. 2007 Jun 1;316(5829):1349-53
pubmed: 17540904
J Exp Med. 2009 Jul 6;206(7):1505-13
pubmed: 19564355
J Immunol. 2002 Jul 15;169(2):739-49
pubmed: 12097376
Nat Commun. 2013;4:2039
pubmed: 23783831
Nat Rev Immunol. 2004 Sep;4(9):688-98
pubmed: 15343368
Mol Cell. 1999 Sep;4(3):395-402
pubmed: 10518220
J Biol Chem. 2019 May 10;294(19):7740-7754
pubmed: 30914481
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20572-7
pubmed: 23188800
J Exp Med. 2021 Apr 5;218(4):
pubmed: 33555295
Nature. 1994 Mar 17;368(6468):215-21
pubmed: 8145819
Science. 1994 Aug 26;265(5176):1234-7
pubmed: 8066463
J Exp Med. 2004 Aug 16;200(4):493-505
pubmed: 15302902
Eur J Immunol. 2009 Apr;39(4):956-64
pubmed: 19283781
J Biol Chem. 1998 Oct 2;273(40):25637-46
pubmed: 9748229
Immunity. 1999 Feb;10(2):207-17
pubmed: 10072073
Cell Rep. 2015 Nov 17;13(7):1432-1443
pubmed: 26549457
Front Immunol. 2017 Mar 17;8:292
pubmed: 28367149
Nat Rev Immunol. 2014 Jun;14(6):377-91
pubmed: 24830344
Annu Rev Immunol. 1993;11:403-50
pubmed: 8476568
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2495-500
pubmed: 9122223
Science. 1998 May 8;280(5365):905-8
pubmed: 9572735
Adv Immunol. 2021;149:1-23
pubmed: 33993918
J Clin Invest. 2011 May;121(5):1810-21
pubmed: 21505262
Nature. 1992 Aug 27;358(6389):764-8
pubmed: 1380674
Nat Commun. 2018 Feb 28;9(1):882
pubmed: 29491378
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7634-8
pubmed: 8755527
Nat Biotechnol. 2018 Oct 22;:
pubmed: 30346938
Science. 1992 Mar 6;255(5049):1261-3
pubmed: 1546328
J Neuroimmunol. 1997 Jun;76(1-2):161-6
pubmed: 9184646
J Immunol. 2018 Feb 15;200(4):1382-1388
pubmed: 29298829
Immunity. 2015 May 19;42(5):942-52
pubmed: 25979422
Nat Immunol. 2001 Apr;2(4):301-6
pubmed: 11276200
Eur J Immunol. 2011 May;41(5):1278-87
pubmed: 21469133
Mol Cell Proteomics. 2015 Dec;14(12):3105-17
pubmed: 26628741
Adv Immunol. 2000;75:159-208
pubmed: 10879284
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5042-7
pubmed: 16549793
Nat Rev Immunol. 2006 Apr;6(4):271-82
pubmed: 16557259
Eur J Immunol. 2004 Oct;34(10):2681-9
pubmed: 15368284
J Immunol. 2019 Feb 1;202(3):966-978
pubmed: 30567730
Nat Immunol. 2015 Oct;16(10):1069-76
pubmed: 26301566
J Clin Pathol. 2021 Feb;74(2):84-90
pubmed: 32467319
Eur J Immunol. 2016 Apr;46(4):846-56
pubmed: 26694097
Mol Biol Cell. 2004 Mar;15(3):1101-11
pubmed: 14699058
Nature. 1991 May 23;351(6324):290-6
pubmed: 1709722
Science. 1998 Apr 17;280(5362):450-3
pubmed: 9545226
J Immunol. 2009 Dec 1;183(11):7278-85
pubmed: 19915056
Nat Methods. 2021 Jun;18(6):604-617
pubmed: 34099939
J Immunol. 1999 Oct 15;163(8):4434-41
pubmed: 10510385
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):674-8
pubmed: 7678462
Nat Commun. 2015 Jun 23;6:7484
pubmed: 26099460
Cell. 1996 Feb 23;84(4):505-7
pubmed: 8598037
Immunity. 1999 Feb;10(2):197-206
pubmed: 10072072
Genome Res. 2014 Dec;24(12):1918-31
pubmed: 25224068
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6979-84
pubmed: 23569244
Curr Opin Immunol. 2009 Feb;21(1):92-7
pubmed: 19246181
Cell. 1989 Feb 10;56(3):327-9
pubmed: 2492449
Nat Immunol. 2016 Aug;17(8):938-45
pubmed: 27294792
J Exp Med. 2002 May 20;195(10):1349-58
pubmed: 12021314
Immunol Lett. 1994 Dec;43(3):189-93
pubmed: 7721331
J Mol Biol. 1991 May 20;219(2):277-319
pubmed: 2038058
Annu Rev Immunol. 2004;22:531-62
pubmed: 15032588
Cell Rep. 2019 Nov 26;29(9):2901-2916.e6
pubmed: 31775054
Science. 1987 Nov 20;238(4830):1073-9
pubmed: 3317824

Auteurs

Izumi Ohigashi (I)

Division of Experimental Immunology, Institute of Advanced Medical Sciences, University of Tokushima, Tokushima, 770-8503, Japan. Electronic address: ohigashi@genome.tokushima-u.ac.jp.

Mami Matsuda-Lennikov (M)

Thymus Biology Section, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

Yousuke Takahama (Y)

Thymus Biology Section, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH